Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘AF14b15-21’. The present disclosure relates to seeds of the hemp plant ‘AF14b15-21’, to plants, parts, and cells of the hemp plant ‘AF14b15-21’, and to methods for producing a hemp plant by crossing the hemp plant ‘AF14b15-21’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: A composition for the treatment of acne. The composition works without drying out the skin and exacerbating the cycle of acne, while promoting healing and reducing inflammation. The composition includes a cannabidiol, terpenoids, an antimicrobial, a soothing agent, a healing agent, or an anti-inflammatory agent, a healthy skin promoter, an antioxidant, and a mild, naturally derived antimicrobial agent. The composition may also include emulsifiers, humectants, preservatives, chelating agents, stabilizers, colorants, and fragrances. The composition may also include oils and fatty acids such as medium chain triglycerides (caprylic/capric triglyceride), Cannabis Sativa (hemp seed) oil, and Nigella Sativa (black cumin) seed oil.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘EM15b2A170’. The present disclosure relates to seeds of the hemp plant ‘EM15b2A170’, to plants, parts, and cells of the hemp plant ‘EM15b2A170’, and to methods for producing a hemp plant by crossing the hemp plant ‘EM15b2A170’ with itself or other Cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: A composition for the treatment of psoriasis, wherein the composition comprises a CB2 receptor binding agent, an immunosuppressive agent an oil; and a healing agent or an anti-inflammatory agent.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: In various embodiments, an implant for interfacing with a bone structure includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue. In some embodiments, a method is provided that includes accessing an intersomatic space and inserting an implant into the intersomatic space. The implant includes a web structure including a space truss. The space truss includes two or more planar truss units having a plurality of struts joined at nodes and the web structure is configured to interface with human bone tissue.

Abstract: A composition for the treatment of acne. The composition works without drying out the skin and exacerbating the cycle of acne, while promoting healing and reducing inflammation. The composition includes a cannabidiol, terpenoids, an antimicrobial, a soothing agent, a healing agent, or an anti-inflammatory agent, a healthy skin promoter, an antioxidant, and a mild, naturally derived antimicrobial agent. The composition may also include emulsifiers, humectants, preservatives, chelating agents, stabilizers, colorants, and fragrances. The composition may also include oils and fatty acids such as medium chain triglycerides (caprylic/capric triglyceride), Cannabis Sativa (hemp seed) oil, and Nigella Sativa (black cumin) seed oil.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: Methods and formulations for providing efficacious pain relief by transdermal delivery of cannabidiol (CBD), the formulations having a high weight ratio of CBD to (?)-trans-?9-tetrahydrocannabinol (THC).

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘LINDOREA’. The present disclosure relates to seeds of the hemp plant ‘LINDOREA,’ to plants and parts of the hemp plant ‘LINDOREA,’ and to methods for producing a hemp plant by crossing the hemp plant ‘LINDOREA’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘KIRSCHE’. The present disclosure relates to seeds of the hemp plant ‘KIRSCHE,’ to plants and parts of the hemp plant ‘KIRSCHE,’ and to methods for producing a hemp plant by crossing the hemp plant ‘KIRSCHE’ with itself or other Cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘CW1AS1’. The present disclosure relates to seeds of the hemp plant ‘CW1AS1,’ to plants and parts of the hemp plant ‘CW1AS1,’ and to methods for producing a hemp plant by crossing the hemp plant ‘CW1AS1’ with itself or other Cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.

Abstract: Apparatuses, methods, and systems for extraction, isolation, purification, and conversion of various cannabinoids, and modifications of whole-plant hemp extracts therewith are presented. A method for preparing a whole-plant hemp extract based product includes extracting cannabinoids from plant materials, such as one or more hemp varieties of Cannabis sativa. The method also includes separating and purifying CBD from the extracted cannabinoids, converting purified CBD to ?9-THC and ?8-THC and concurrently converting ?9-THC to CBN, purifying and separating the CBN, and combining the purified CBN with a whole-plan hemp extract. Products and supplements related to the method are also described.

Abstract: The present disclosure provides a new and distinct hemp cultivar designated ‘CW1AS1’. The present disclosure relates to seeds of the hemp plant ‘CW1AS1,’ to plants and parts of the hemp plant ‘CW1AS1,’ and to methods for producing a hemp plant by crossing the hemp plant ‘CW1AS1’ with itself or other cannabis plants. The disclosure further relates to the morphological and physiological characteristics of the new and distinct hemp cultivar and its uses.